Emerging as a promising avenue for treating the disabling effects of MS Disease, stem cell therapy is increasingly gaining traction within the neurological sector. While not a remedy, this groundbreaking approach aims to restore damaged myelin tissue and mitigate neurological decline. Several investigations are currently being conducted, exploring